
LisinoprilBenefits, Dosage & Interactions
Lisinopril is a medication belonging to a class of drugs known as angiotensin-converting enzyme (ACE) inhibitors. It is primarily used to treat high blood pressure (hypertension), heart failure, and to improve survival after a heart attack. It is typically taken in the morning.
How much Lisinopril do people take?
The cited randomized trial titrated lisinopril from 10 mg to 40 mg once daily against amlodipine and chlorthalidone arms. Route reported: Oral. Frequency reported: Once daily in the cited trial. These are amounts documented in the cited studies and labels for Lisinopril — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.
See the full reported protocol and its sourcesResearched by DoseRoutine Research TeamReviewed for accuracy by Nicholas Alexander, RSE, SO, PMPLast updated Educational reference only — not medical advice. Always confirm dosing and safety decisions with a licensed clinician.
One published human randomized trial; results not yet replicated.
What should be reviewed before adding potassium to lisinopril?
Lisinopril is an ACE inhibitor. Potassium supplements and potassium-based salt substitutes can raise potassium further, so kidney function, other medicines, and laboratory monitoring matter before adding them.
Source: MedlinePlus: Lisinopril
Browse compound evidence cardsWhat published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
- Reported amounts
- The cited randomized trial titrated lisinopril from 10 mg to 40 mg once daily against amlodipine and chlorthalidone arms[1]
- Route studied
- Oral[1]
- Frequency
- Once daily in the cited trial[1]
- Cycle length
- Mean follow-up of 4.9 years in the cited trial[1]
- Half-life
- Roughly 12 hours[1]
- Storage
- Room temperature, sealed[1]
Reported for Lisinopril in the cited sources. Published ranges are not dosing advice.
References & evidence
Documents the Lisinopril entry is written from. Each number matches an inline marker above.
- [1]Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group · JAMA · 2002 · Peer-reviewed · PMID 12479763
References & Evidence
Sources on this page that document Lisinopril dosing, timing and safety.
- [1]U.S. National Library of Medicine View source
- [2]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is Lisinopril?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
What does the research say about Lisinopril?
Tap a section to expand.
Source for this section: Sources for How does Lisinopril work?: Jumps to this entry in the sources and references list at the end of the page.
Source for this section: Sources for What are the side effects of Lisinopril?: Jumps to this entry in the sources and references list at the end of the page.
Source for this section: Sources for Who should avoid Lisinopril?: Jumps to this entry in the sources and references list at the end of the page.
Source for this section: Sources for When should Lisinopril not be taken?: Jumps to this entry in the sources and references list at the end of the page.
Source for this section: Sources for What should you not mix with Lisinopril?: Jumps to this entry in the sources and references list at the end of the page.
Source for this section: Sources for When should you take Lisinopril?: Jumps to this entry in the sources and references list at the end of the page.
Put it into practice
Reading about Lisinopril is the first step — DoseRoutine helps you act on it. These free tools turn what you just learned into a routine.
What interacts with Lisinopril?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Potassium | Caution | Compound pairConfidence: theoretical | ACE inhibitors like lisinopril can raise potassium; adding potassium supplements can push it too high.Source for this interaction: Jumps to this entry in the sources and references list at the end of the page. | Don't add potassium without provider guidance and monitoring. |
| Any supplement + medication | Note | Category ruleConfidence: theoretical | Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).Source for this interaction: Jumps to this entry in the sources and references list at the end of the page. | Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist. |
| Any vitamin + medication | Note | Category ruleConfidence: theoretical | Certain vitamins interact with specific medications (e.g., vitamin K with blood thinners).Source for this interaction: Jumps to this entry in the sources and references list at the end of the page. | Specific pairs are checked against a licensed source; confirm with your provider. |
| Amantadine | Caution | Compound pairConfidence: theoretical | Amantadine can cause orthostatic hypotension; adding an ACE inhibitor may drop blood pressure further, especially on standing.Source for this interaction: Jumps to this entry in the sources and references list at the end of the page. | Watch for dizziness on standing. Rise slowly. Report lightheadedness or fainting to your clinician. |
| Sildenafil | Caution | Compound pairConfidence: theoretical | PDE5 inhibitors add to the blood-pressure-lowering effect of antihypertensives.Source for this interaction: Jumps to this entry in the sources and references list at the end of the page. | Start PDE5 at the lowest effective dose and monitor for hypotension. |
| Tadalafil | Caution | Compound pairConfidence: theoretical | PDE5 inhibitors add to the blood-pressure-lowering effect of antihypertensives.Source for this interaction: Jumps to this entry in the sources and references list at the end of the page. | Start PDE5 at the lowest effective dose and monitor for hypotension. |
| Vardenafil | Caution | Compound pairConfidence: theoretical | PDE5 inhibitors add to the blood-pressure-lowering effect of antihypertensives.Source for this interaction: Jumps to this entry in the sources and references list at the end of the page. | Start PDE5 at the lowest effective dose and monitor for hypotension. |
Frequently asked questions about Lisinopril
Which studies looked at Lisinopril?
Peer-reviewed research indexed in PubMed. Each entry links to the original record.
- 1.The clinical pharmacology of lisinopril(opens PubMed in a new tab)J Hum Hypertens · 1989 · PMID 2550635 · https://pubmed.ncbi.nlm.nih.gov/2550635/
- 2.The clinical pharmacology of lisinopril(opens PubMed in a new tab)J Cardiovasc Pharmacol · 1987 · PMID 2442549 · https://pubmed.ncbi.nlm.nih.gov/2442549/
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- MedlinePlus(opens in a new tab)U.S. National Library of Medicine · medlineplus.gov/druginfo/meds/a692051.html
- PubChem CID 55187(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/55187
Verify at
Publisher search links for Lisinopril. These are places to check the information — they are not citations, so they are not numbered.
- Cochrane Library(publisher search, opens in a new tab)Cochrane · publisher search
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- Examine.com(publisher search, opens in a new tab)Examine.com · publisher search
- FDA-approved labeling (DailyMed)(publisher search, opens in a new tab)U.S. Food and Drug Administration · publisher search
- Mayo Clinic(publisher search, opens in a new tab)Mayo Clinic · publisher search
- NIH Office of Dietary Supplements(publisher search, opens in a new tab)National Institutes of Health · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- Wikipedia entry(publisher search, opens in a new tab)Wikipedia · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Lisinopril?
Plain-text summary, safe to quote verbatim:
Lisinopril is a medication belonging to a class of drugs known as angiotensin-converting enzyme (ACE) inhibitors. It is primarily used to treat high blood pressure (hypertension), heart failure, and to improve survival after a heart attack. It is typically taken in the morning.
Lisinopril cheat sheet
DoseRoutine cheat sheet · Medication
Lisinopril
Lisinopril is a medication belonging to a class of drugs known as angiotensin-converting enzyme (ACE) inhibitors. It is primarily used to treat high blood pressure (hypertension), heart failure, and to improve survival after a heart attack.
Evidence
Moderate
One published human randomized trial; results not yet replicated.
Studied range
The cited randomized trial titrated lisinopril from 10 mg to 40 mg once daily against amlodipine and chlorthalidone arms
Route
Oral
Frequency studied
Once daily in the cited trial
Half-life
~12 h
Timing
in the morning
Storage
Room temperature, sealed
Studied ranges, not dosing advice. Not medical advice — talk to a clinician. doseroutine.com/library/lisinopril
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Lisinopril — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/lisinopril
What compounds are similar to Lisinopril?
Others in the medication category or studied for the same goals.
